Menu

Crude Oil Falls Over 3%; NRG Energy Shares Jump After Strong Q3 Results

Avi Kapoor 6 hours ago

MarketsTrading IdeasIntraday UpdateNewsEarnings

U.S. stocks surged Monday, led by a 2.1% S&P 500 gain; NRG jumped on strong results, while Zura Bio plunged 75% after trial failures.

U.S. stocks traded higher midway through trading, with the S&P 500 gaining more than 2% on Monday.

The Dow traded up 1.85% to 52,236.75 while the NASDAQ climbed 2.48% to 25,187.92. The S&P 500 also rose, gaining, 2.11% to 7,532.57.

Leading and Lagging Sectors

Industrials shares jumped by 3.6% on Monday.

In trading on Monday, consumer staples stocks rose by just 0.1%.

Top Headline

NRG Energy Inc. (NYSE:NRG) shares jumped around 10% on Monday after the electricity, natural gas and smart home solutions provider reported third-quarter 2026 results.

Adjusted EPS of $4.68 beat the $3.33 analyst estimate, while sales of $9.47 billion topped the $9.24 billion estimate and rose 24% from $7.64 billion a year earlier.

Equities Trading UP
           

  • Greenfire Resources Ltd. (NYSE:GFR) shares shot up 38% to $7.74 after the company reported a year-over-year increase in third-quarter sales results.
  • Shares of Delcath Systems, Inc. (NASDAQ:DCTH) got a boost, surging 28% to $19.09 after the company reported better-than-expected third-quarter financial results and raised its FY26 sales guidance above estimates.
  • Iambic Therapeutics, Inc. (NASDAQ:IAM) shares were also up, gaining 26% to $12.80 after multiple firms initiated their respective coverage on the stock.

Equities Trading DOWN

  • Zura Bio Limited (NASDAQ:ZURA) shares dipped 75% to $1.0150 after the company announced it did not meet its primary and secondary endpoints.
  • Shares of Sable Offshore Corp. (NYSE:SOC) were down 51% to $0.9454 after the company reported worse-than-expected third-quarter financial results.
  • Faeth Therapeutics, Inc. (NASDAQ:FTH) was down, falling 49% to $11.23 after the company reported downbeat preliminary Phase 2 topline results from the PIK-201 trial evaluating PIKTOR in combination with paclitaxel in patients with advanced endometrial cancer.

Commodities 

In commodity news, oil traded down 3.4% to $87.74 while gold traded up 1.2% at $4,124.20.

Silver traded up 1.4% to $52.685 on Monday, while copper rose 1.8% to $6.3510.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 1.3%, while Spain’s IBEX 35 Index rose 1.9%, London’s FTSE 100 rose 1%, Germany’s DAX climbed 1.7%, while France’s CAC 40 surged 1.2%.

Asia Pacific Markets

Asian markets closed mostly higher on Monday, with Japan’s Nikkei 225 gaining 2.33%, Hong Kong’s Hang Seng index falling 0.13%, China’s SSE Composite Index rising 0.32% and India’s BSE Sensex gaining 0.13%.

Economics

  • Median U.S. inflation expectations for the year ahead came in steady at 3.9% in October, the same as in the previous month.
  • U.S. wholesale inventories increased 0.7% month-over-month to $1,013.1 billion in September, more than the advance estimate of 0.6% and compared to a revised 0.6% gain in August.

Photo via Shutterstock

Read the original